File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Safety, tolerability, pharmacokinetics and antiviral activity of AL-3778, a first-in-class, HBV core assembly modulator alone and in combination with peginterferon-alpha 2A, in treatment naive HBeAg-positive chronic hepatitis B patients

TitleSafety, tolerability, pharmacokinetics and antiviral activity of AL-3778, a first-in-class, HBV core assembly modulator alone and in combination with peginterferon-alpha 2A, in treatment naive HBeAg-positive chronic hepatitis B patients
Authors
Kennedy, WYuen, RMFKim, DJWeilert, FChan, HLYLalezari, JHwang, SGNguyen, TWestland, CKakuda, TBrown, NKlumpp, KFlores, LTalloen, WLenz, OGane, Evan Remoortere, PChandra, SFry, J
Issue Date2017
PublisherSpringer New York LLC. The Journal's web site is located at http://www.springer.com/west/home/medicine?SGWID=4-10054-70-173733513-0
Citation
Abstracts of the 26th Annual Conference of the Asian Pacific Association for the Study of the Liver (APASL), Shanghai, China, 15-19 February 2017. In Hepatology International, 2017, v. 11 n. Suppl. 1, p. S7-S8, abstract no. PL012 How to Cite?
DescriptionPlenary Presentation 02 : paper no. PL012
Persistent Identifierhttp://hdl.handle.net/10722/245570
ISSN
1936-0533
2021 Impact Factor: 9.029
2020 SCImago Journal Rankings: 1.304

 

DC FieldValueLanguage
dc.contributor.authorKennedy, W-
dc.contributor.authorYuen, RMF-
dc.contributor.authorKim, DJ-
dc.contributor.authorWeilert, F-
dc.contributor.authorChan, HLY-
dc.contributor.authorLalezari, J-
dc.contributor.authorHwang, SG-
dc.contributor.authorNguyen, T-
dc.contributor.authorWestland, C-
dc.contributor.authorKakuda, T-
dc.contributor.authorBrown, N-
dc.contributor.authorKlumpp, K-
dc.contributor.authorFlores, L-
dc.contributor.authorTalloen, W-
dc.contributor.authorLenz, O-
dc.contributor.authorGane, E-
dc.contributor.authorvan Remoortere, P-
dc.contributor.authorChandra, S-
dc.contributor.authorFry, J-
dc.date.accessioned2017-09-18T02:13:01Z-
dc.date.available2017-09-18T02:13:01Z-
dc.date.issued2017-
dc.identifier.citationAbstracts of the 26th Annual Conference of the Asian Pacific Association for the Study of the Liver (APASL), Shanghai, China, 15-19 February 2017. In Hepatology International, 2017, v. 11 n. Suppl. 1, p. S7-S8, abstract no. PL012-
dc.identifier.issn1936-0533-
dc.identifier.urihttp://hdl.handle.net/10722/245570-
dc.descriptionPlenary Presentation 02 : paper no. PL012-
dc.languageeng-
dc.publisherSpringer New York LLC. The Journal's web site is located at http://www.springer.com/west/home/medicine?SGWID=4-10054-70-173733513-0-
dc.relation.ispartofHepatology International-
dc.titleSafety, tolerability, pharmacokinetics and antiviral activity of AL-3778, a first-in-class, HBV core assembly modulator alone and in combination with peginterferon-alpha 2A, in treatment naive HBeAg-positive chronic hepatitis B patients-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros278503-
dc.identifier.volume11-
dc.identifier.issueSuppl. 1-
dc.identifier.spageS7-
dc.identifier.epageS8-
dc.publisher.placeUnited States-
dc.identifier.issnl1936-0533-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats